Aquestive Therapeutics
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.sympazan.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Aquestive Therapeutics
Assertio Holdings, Inc. offers SYMPAZAN, a unique oral film formulation of clobazam used to treat seizures associated with Lennox-Gastaut Syndrome in patients aged 2 years and older. The product is designed for both patients and healthcare professionals, providing resources, prescribing information, and safety guidelines. SYMPAZAN's innovative delivery method allows it to dissolve on the tongue, enhancing patient compliance. The company emphasizes safety information related to the drug's use, including risks of dependence and adverse reactions.Explore more
Popular SearchesAquestive Therapeutics IncSympazanOtter Pharmaceuticals LLCSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aquestive Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Aquestive Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Aquestive Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aquestive Therapeutics
Earning: See what the market has to say on Aquestive Therapeutics recently announced quarterly report
Check out if Aquestive Therapeutics is spiking on competitors!
Click to see if Aquestive Therapeutics had a recent Job posting/layoffs
Check if Aquestive Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Aquestive Therapeutics launches new products
Recommended Actions
Find VP level buyers at Aquestive Therapeutics
Find 3 more new buyers
Compare Similar Companies to Aquestive Therapeutics
Compare insights from companies similar to Aquestive Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aquestive Therapeutics
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Aquestive Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aquestive Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aquestive Therapeutics.
Aquestive Therapeutics Tech Stack
A closer look at the technologies used by Aquestive Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aquestive Therapeutics
Sign Up For FreeTo access detailed company insights
Assertio Holdings, Inc. offers SYMPAZAN, a unique oral film formulation of clobazam used to treat seizures associated with Lennox-Gastaut Syndrome in patients aged 2 years and older. The product is designed for both patients and healthcare professionals, providing resources, prescribing information, and safety guidelines. SYMPAZAN's innovative deli... Read More
